CRB Inverbío
Cross Road Biotech Inversiones Biotecnológicas (CRB Inverbío SGECR SA) is a venture capital management firm registered with number 87 in the CNMV. CRB Inverbío manages Venture Capital Firms that invest in the development of seed stage companies in life sciences that address unmet medical needs and have the potential to grow into successful businesses. To that end, the company selects innovative projects led by prestigious scientists and entrepreneurs, providing financing, management support and strategic advice.
Recent Milestones
Investments
| Company |
Date |
Round |
Size |
Participants |
| Amadix | 2/13 | Venture Round | €2M | 2 |
Videos
Sources
-
Amadix Merges with Transbiomed and Raises €2M in Funding (finsmes.com)
[edit]
